Compare Heron Therapeutics Inc (HRTX) vs Global X Lithium & Battery Tech ETF (LIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Global X Lithium & Battery Tech ETF — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $74.04M), while Global X Lithium & Battery Tech ETF trades at $69.02 (market cap $1.49B). The key difference: Global X Lithium & Battery Tech ETF is far larger — about 20.1× Heron Therapeutics Inc's market cap, and Global X Lithium & Battery Tech ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Global X Lithium & Battery Tech ETF for 56 Days on average.
| HRTX | LIT | |
|---|---|---|
Market Cap | $74.04M | $1.49B |
Volume | 3,668,095 | 67,221 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $1.49 | $91.62 |
52-Week Low | $0.27 | $53.92 |
Typical Hold Time | 35 Days | 56 Days |
Enterprise Value | $180.78M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.
The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.
LIT trades at $69.51, down 2.2% today amid mixed technical signals with a bullish overall rating but bearish moving averages and oscillators. The ETF's recent performance reflects volatility in lithium markets, with short interest dropping 53.1% in September. Key technical levels show support at $70 and resistance at $72. Recent news highlights ongoing EV sector growth with China targeting 30% NEV fleet by 2030, providing long-term tailwinds.
LIT offers exposure to the expanding battery technology sector with catalysts from EV adoption and energy storage demand. However, risks include lithium price volatility and Chinese export controls. The ETF's momentum is supported by semiconductor and AI-driven battery demand, though current technical indicators suggest near-term consolidation may precede further upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Global X Lithium & Battery Tech ETF
LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →
